Watson Launches Authorized Oxandrin Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Launch follows denial of Savient’s motion for preliminary injunction to prevent Sandoz and Upsher-Smith from launching generic oral anabolic agent.